The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...

GE HealthCare Technologies, Inc. GEHC announced that it has received FDA approval for Flyrcado (flurpiridaz F 18), a ...

Analyst Larry Biegelsen from Wells Fargo maintained a Buy rating on GE Healthcare Technologies Inc (GEHC – Research Report) and keeping ...

GE Healthcare Technologies Inc. received U.S. FDA approval for its novel radiotracer, Flyrcado (flurpiridaz F-18), for use in ...

The injectable tracer, Flyrcado, could help doctors flag deadly coronary artery disease in patients during imaging tests.

GE HealthCare shares are up nearly 1% after getting the green light late Friday from U.S. regulators to sell a new diagnostic imaging agent that analysts say could be a big seller for the [General Ele ...

GE HealthCare has received approval for Flyrcado, its enhanced diagnosis tool for coronary heart disease, from the Food and Drug Administration. The company said on Friday that Flyrcado, or ...

GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease ...

Bristol Myers gains FDA approval for a new schizophrenia drug. HHS declares a health emergency in Georgia due to Hurricane ...

Current health news includes the declaration of a public health emergency in Georgia due to Hurricane Helene, the slow uptake ...

GE HealthCare (GEHC) was cut to sell by UBS on Thursday, with the bank asserting that risks such as increasing Chinese ...

Fintel reports that on September 26, 2024, UBS downgraded their outlook for GE HealthCare Technologies ( BVC:GEHC) from ...